Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Press Releases

Press ReleasesSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

All Releases
View Summary Spectrum Pharmaceuticals Announces Second Quarter 2015 Financial Results Teleconference and Webcast
Jul 30, 2015
PDF 14.2 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Publication of Beleodaq® Data Selected as a Rapid Communication in the Journal of Clinical Oncology
Jun 24, 2015
PDF 72.6 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Highlights Five Abstracts of Clinical Data at the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, May 29-June 2, 2015
May 29, 2015
PDF 15.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies Global Healthcare Conference in New York City on June 3rd
May 28, 2015
PDF 13.4 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Commits to Review Shareholder Proposal
May 14, 2015
PDF 13.0 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Continued Advancement of Robust, Late-Stage Pipeline and First Quarter 2015 Financial Results
May 7, 2015
PDF 83.9 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces First Quarter 2015 Financial Results Teleconference and Webcast
Apr 30, 2015
PDF 59.8 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Presents New Data on EVOMELATM (CE-Melphalan), at the Annual Meeting of the American Pharmacists Association (APhA) in San Diego, Highlighting Stability
Mar 30, 2015
PDF 63.2 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Robust Clinical Data and Strong 2014 Financial Results
Mar 13, 2015
PDF 93.9 KB Add to Briefcase
View Summary Four Oncology Key Opinion Leaders to Present at Spectrum Pharmaceuticals' Analyst Day on Friday, March 13th
Mar 11, 2015
PDF 61.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces FDA's Acceptance of NDA Filing for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan
Mar 9, 2015
PDF 62.7 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals In-Licenses Poziotinib, a Novel pan-HER Inhibitor With Clinical Activity in Several Solid Tumors, From Hanmi Pharmaceuticals
Mar 4, 2015
PDF 62.3 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the 2015 RBC Capital Markets' Global Healthcare Conference on February 24th
Feb 20, 2015
PDF 59.0 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Fourth Quarter 2014 Financial Results and Analyst Day
Feb 17, 2015
PDF 61.5 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Highlights Clinical Data for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan at the 2015 BMT Tandem Meeting
Feb 12, 2015
PDF 65.0 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Files a New Drug Application with the FDA for Captisol-Enabled™ (Propylene Glycol-Free) Melphalan
Dec 26, 2014
PDF 61.1 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Highlights 11 Abstracts at the 56th Annual Meeting of the American Society of Hematology (ASH) in San Francisco, California, December 6-9, 2014
Dec 5, 2014
PDF 29.7 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2014 Global London Healthcare Conference on November 19th
Nov 12, 2014
PDF 12.3 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Reports Strong Product Sales for the Third Quarter 2014; Sales of $47.9 Million up 15.6% Over Last Year
Nov 6, 2014
PDF 47.4 KB Add to Briefcase
View Summary Spectrum Pharmaceuticals Announces Third Quarter 2014 Financial Results Teleconference and Webcast
Oct 30, 2014
PDF 13.8 KB Add to Briefcase
Showing 1-20 of 651 Page: 1 2 3 4 5 ... 33  Next 20
Add to Briefcase = add release to Briefcase

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPISpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Price:
6.92
Change:
+ 0.15
Day High:
7.07
Day Low:
6.71
Volume:
625,100
4:00 PM ET on Jul 31, 2015
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder ToolsSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

Print Email

Search IRSpectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company